The TORCH Panel IgG test is a blood test that measures IgG antibodies against infections such as Toxoplasmosis, Rubella, Cytomegalovirus (CMV), and Herpes simplex virus (HSV). Unlike IgM, which indicates recent infection, IgG reflects past exposure or immunity, showing whether the body has previously encountered these pathogens. Healthcare professionals often recommend this test during pregnancy to assess maternal immunity and evaluate risks of congenital infections, helping guide preventive measures and ensuring better protection for both mother and baby.
IgG antibodies reflect past infection or immunity, meaning the body has previously encountered the pathogen and developed long-term protection.
The panel covers Toxoplasmosis, Other (like syphilis), Rubella, Cytomegalovirus, and Herpes simplex virus.
It indicates past exposure or immunity to one of the TORCH pathogens, which may protect against reinfection.
It suggests no prior exposure or immunity, meaning the person may be at risk if exposed during pregnancy.
Yes, if the mother lacks immunity and acquires infection during pregnancy, it can cause congenital abnormalities or complications.
No, it can also be used for individuals with suspected infections, but it’s most critical during pregnancy.
Yes, many can be managed with antiviral or antibiotic medications, reducing risks to mother and child.